Sawai Group (OTCMKTS:SWGHF – Get Free Report) is expected to issue its results after the market closes on Friday, November 13th. Analysts expect Sawai Group to announce earnings of $0.2811 per share and revenue of $325.60 million for the quarter.
Sawai Group Stock Performance
SWGHF opened at $11.85 on Thursday. Sawai Group has a 1-year low of $11.52 and a 1-year high of $12.03. The firm’s 50 day simple moving average is $11.95 and its two-hundred day simple moving average is $12.01.
Sawai Group Company Profile
Sawai Group Holdings Co., Ltd. is a Japanese pharmaceutical company focused on developing, manufacturing and selling generic prescription medicines. Its products span a range of therapeutic areas and are marketed primarily to healthcare providers and patients in Japan. The group traces its roots to Sawai Pharmaceutical, founded in 1929. Sawai Group Holdings was established as a holding company in 2021, with Sawai Pharmaceutical as its principal operating company. Through its pharmaceutical operations, the group works to provide lower-cost alternatives to brand-name medicines.
Read More
- Five stocks we like better than Sawai Group
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Sawai Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sawai Group and related companies with MarketBeat.com's FREE daily email newsletter.
